C021 Post hoc Analysis: Effects of Reducing Lamotrigine or Carbamazepine Dose in Patients With Uncontrolled Focal Seizures Receiving Cenobamate

April 17 – 22, 2021; Virtual Meeting
Analysis of seizure-free patients suggests dose of ASMs may be able to be reduced while receiving concomitant cenobamate, without compromising long-term efficacy.
Format: Microsoft PowerPoint (.ppt)
File Size: 495 KB
Released: April 26, 2021

Acknowledgements

Provided by Clinical Care Options

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Greenwich Biosciences, Inc.

Related Content

From CCO: Companion Migraine Comorbidities slideset with highlights from Do-It-Better RealCME on Improving Migraine Treatment, and Prevention.

Jessica Ailani, MD Released: June 25, 2020

From CCO: companion migraine prophylaxis slideset with highlights from Do-It-Better RealCME on improving migraine treatment, and prevention

Wade Cooper, DO Released: June 25, 2020

Expert-authored slideset with latest data on migraine prophylaxis using CGRP-targeting monoclonal antibodies, gepants, ditans, and tritans, from CCO.

Wade Cooper, DO Merle Diamond, MD Released: February 14, 2020

Faculty respond to frequently asked questions on diagnosing and managing progressive MS.

Released: December 4, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue